These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8522279)

  • 21. Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome.
    Zeger MP; Shah K; Kowal K; Cutler GB; Kushner H; Ross JL
    Horm Res Paediatr; 2011; 75(1):38-46. PubMed ID: 20733274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant growth hormone in children and adolescents with Turner syndrome.
    Cave CB; Bryant J; Milne R
    Cochrane Database Syst Rev; 2003; (3):CD003887. PubMed ID: 12917993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Final height in Turner syndrome patients treated with growth hormone.
    Pasquino AM; Passeri F; Municchi G; Segni M; Pucarelli I; Larizza D; Bossi G; Severi F; Galasso C
    Horm Res; 1996; 46(6):269-72. PubMed ID: 8982737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demography, auxology and response to recombinant human growth hormone treatment in girls with Turner's syndrome in the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study.
    Price DA; Albertsson-Wikland K
    Acta Paediatr Suppl; 1993 Sep; 82 Suppl 391():69-74. PubMed ID: 8219480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with growth hormone therapy in Turner syndrome in a single centre: low total height gain, no further gains after puberty onset and unchanged body proportions.
    Schweizer R; Ranke MB; Binder G; Herdach F; Zapadlo M; Grauer ML; Schwarze CP; Wollmann HA
    Horm Res; 2000; 53(5):228-38. PubMed ID: 11150884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short- and long-term (final height) growth responses to growth hormone (GH) therapy in patients with Turner syndrome: correlation of growth response to stimulated GH levels, spontaneous GH secretion, and karyotype.
    Schmitt K; Haeusler G; Blümel P; Plöchl E; Frisch H
    Horm Res; 1997; 47(2):67-72. PubMed ID: 9030970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of oxandrolone and timing of pubertal induction on final height in Turner syndrome: final analysis of the UK randomised placebo-controlled trial.
    Gault EJ; Cole TJ; Casey S; Hindmarsh PC; Betts P; Dunger DB; Donaldson MDC
    Arch Dis Child; 2021 Jan; 106(1):74-76. PubMed ID: 31862699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effects of growth hormone treatment on height in Turner syndrome: results of a 6-year multicentre study in Japan. Committee for the Treatment of Turner Syndrome.
    Takano K; Shizume K; Hibi I; Ogawa M; Okada Y; Suwa S; Tanaka T; Hizuka N
    Horm Res; 1995; 43(4):141-3. PubMed ID: 7750916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of growth in Turner syndrome patients treated with growth hormone: summary of three-year results.
    Rosenfeld RG
    J Endocrinol Invest; 1989; 12(8 Suppl 3):49-51. PubMed ID: 2681348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone therapy in Turner syndrome. Analysis of long-term results.
    Ranke MB
    Horm Res; 1995; 44 Suppl 3():35-41. PubMed ID: 8719439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Final height after long-term growth hormone treatment in Turner syndrome. European Study Group.
    Van den Broeck J; Massa GG; Attanasio A; Matranga A; Chaussain JL; Price DA; Aarskog D; Wit JM
    J Pediatr; 1995 Nov; 127(5):729-35. PubMed ID: 7472824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens.
    van Pareren YK; de Muinck Keizer-Schrama SM; Stijnen T; Sas TC; Jansen M; Otten BJ; Hoorweg-Nijman JJ; Vulsma T; Stokvis-Brantsma WH; Rouwé CW; Reeser HM; Gerver WJ; Gosen JJ; Rongen-Westerlaken C; Drop SL
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1119-25. PubMed ID: 12629094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-year results of treatment with methionyl human growth hormone in children with Turner syndrome. Dutch Growth Hormone Working Group.
    Rongen-Westerlaken C; Fokker MH; Wit JM; De Muinck Keizer-Schrama SM; Otten BJ; Oostdijk W; Delemarre van den waal HA; Gons MH; Bot A
    Acta Paediatr Scand; 1990; 79(6-7):658-63. PubMed ID: 2386058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of growth hormone and oxandrolone singly and together on growth rate in girls with X chromosome abnormalities.
    Rudman D; Goldsmith M; Kutner M; Blackston D
    J Pediatr; 1980 Jan; 96(1):132-5. PubMed ID: 7350294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Three-year results of treatment with growth hormone, alone or associated with oxandrolone, in girls with Turner syndrome. The Kabi Collaborative Study Group.
    Job JC; Landier F
    Horm Res; 1991; 35(6):229-33. PubMed ID: 1819547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-conventional growth hormone therapy in Turner syndrome: the United States experience.
    Rosenfeld RG
    Horm Res; 1990; 33(2-4):137-40; discussion 140-2. PubMed ID: 2210618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group.
    Chernausek SD; Attie KM; Cara JF; Rosenfeld RG; Frane J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2439-45. PubMed ID: 10902791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of bone mass in Turner syndrome].
    Cancer Gaspar E; Ruiz-Echarri Zelaya M; Labarta Aizpún JI; Mayayo Dehesa E; Ferrández Longás A
    An Pediatr (Barc); 2005 May; 62(5):441-9. PubMed ID: 15871826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Final Adult Height after Growth Hormone Treatment in Patients with Turner Syndrome.
    Ahn JM; Suh JH; Kwon AR; Chae HW; Kim HS
    Horm Res Paediatr; 2019; 91(6):373-379. PubMed ID: 31480041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human growth hormone and oxandrolone in treatment of short stature in girls with Turner syndrome.
    Stahnke N; Stubbe P; Keller E
    Horm Res; 1992; 37 Suppl 2():37-46. PubMed ID: 1490666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.